The degradation of DNMT1 and DNMT3B prompts the demethylation of the promoter of the silenced tumour suppressor gene RASSF1A, leading to the restoration of its expression in prostate cancer cells (Figure 6). The gene discussed is RASSF1; the disease is prostate carcinoma.